2015
Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer
Oostra D, Lustberg M, Reinbolt R, Pan X, Wesolowski R, Shapiro C. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. Molecular And Cellular Endocrinology 2015, 402: 51-56. PMID: 25575458, PMCID: PMC4316829, DOI: 10.1016/j.mce.2014.12.028.Peer-Reviewed Original ResearchConceptsBone mineral densityRapid bone lossFollicle stimulating hormoneBone lossAdjuvant chemotherapyOPG levelsFemoral neckBone resorptionBreast cancerLumbar spineStage I/II breast cancerLS bone mineral densityEarly-stage breast cancerAssociation of osteoprotegerinMonths of amenorrheaMIU/mLNegative pregnancy testNuclear factor kappaChemotherapy initiationPremenopausal womenFSH levelsOsteoclast activationMineral densityStimulating hormonePregnancy test
2012
Bone Health in Adult Cancer Survivorship
Lustberg M, Reinbolt R, Shapiro C. Bone Health in Adult Cancer Survivorship. Journal Of Clinical Oncology 2012, 30: 3665-3674. PMID: 23008309, DOI: 10.1200/jco.2012.42.2097.Peer-Reviewed Original ResearchConceptsBone lossOsteoporotic fracture riskCancer treatmentCancer survivorsChemotherapy-induced ovarian failureGonadotropin-releasing hormone agonistDual-energy X-ray absorptiometryFracture assessment toolAndrogen deprivation therapyBone mineral density measurementsVitamin D supplementationMonoclonal antibody therapyLack of exerciseX-ray absorptiometryMineral density measurementsAdult cancer survivorshipHealthy bone remodelingBisphosphonate therapyD supplementationDeprivation therapySurgical oophorectomyAntibody therapyBone healthHormone agonistOsteoporotic fractures